Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
Akorn Signs Supply Pact with Fresenius Kabi

April 3, 2008
Akorn, Inc. has signed a five-year supply agreement with Fresenius Kabi for a new premix product. Premix medications are ready to use intravenous drug products.     Under the terms of the agreement, Akorn will be responsible for de…  Read More »
Metrics Expands Stability Storage

April 3, 2008
Metrics, Inc. is expanding its stability storage, boosting its capacity for service by 50%. The $18-million, 47,000-sq.-ft. expansion will include new state-of-the-art environmental specialties (ESI) chambers with redundant mechanical systems that wi…  Read More »
MDS Pharma Services

April 2, 2008
Teresa F. Winslow has been named senior vice president, global business development and James Miskel has been appointed vice president, strategy and corporate development, MDS Pharma Services. Ms. Winslow will direct global business development effor…  Read More »
Pfizer Cancels Melanoma MAb in Phase III

April 2, 2008
Pfizer has discontinued a Phase III clinical trial of single-agent tremelimumab (CP-675,206) in patients with advanced melanoma, after the review of interim data showed that the trial would not demonstrate superiority to standard chemotherapy. The…  Read More »
Abraxis Starts Phase II Enrollment for Coroxane

April 2, 2008
Abraxis BioScience, Inc. has initiated enrollment in its Phase II clinical trial to evaluate the efficacy and safety of Coroxane for the prevention and reduction of restenosis following revascularization of the superficial femoral artery (SFA). Co…  Read More »
Dr. Reddy's To Acquire Dow Small Molecules Units

April 1, 2008
Dr. Reddy’s Laboratories has entered into a definitive agreement with The Dow Chemical Company to acquire a portion of the Dowpharma Small Molecules business associated with sites in Mirfield and Cambridge, UK. The acquisition will include…  Read More »
Medicis

April 1, 2008
Medicis has announced the promotions of Mark A. Prygocki to executive vice president, chief operating officer, Vincent Ippolito to executive vice president, sales and marketing, and Richard D. Peterson to executive vice president, chief financial off…  Read More »
PPD

April 1, 2008
Mike Wilkinson, Ph.D. has been named executive vice president of global clinical development at PPD, Inc. He will provide strategic leadership to the company's Phase II-IV operations in North America, Latin America, Europe, Middle East/Africa and Asi…  Read More »
ImClone

March 31, 2008
Kenneth J. Zuerblis has been named senior vice president and chief financial officer at ImClone Systems. Mr. Zuerblis has more than 25 years of experience in financial and operational management. He previously served as chief financial officer of Enz…  Read More »
Medarex Gains Novo Nordisk Milestone

March 31, 2008
Medarex, Inc. will receive a milestone payment for an undisclosed amount from its licensing partner, Novo Nordisk A/S. The payment is a result of the submission of an IND by Novo Nordisk for the clinical development of an antibody generated by Medare…  Read More »
Teva To Buy Bentley

March 31, 2008
Teva Pharmaceutical Industries Ltd. has entered an agreement to buy Bentley Pharmaceuticals. The move will follow the spin-off of Bentley's drug delivery business, which was announced in October 2007. Teva will spend approximately $360 million to acq…  Read More »
Cytovance Biologics

March 28, 2008
Darren Head has been named chief executive officer of Cytovance, a bio-CMO specializing in the production of therapeutic proteins and antibodies from mammalian cell culture. Mr. Head was previously at Immucor, where he served as vice president of…  Read More »
Catalent Pharma Solutions

March 28, 2008
Matthew M. Walsh has been named senior vice president, finance and chief financial officer at Catalent Pharma Solutions, effective April 7, 2008. David A. Eatwell, the incumbent in this role, will be leaving Catalent effective April 4, 2008 to pursue…  Read More »
Legacy Pharmaceutiucals

March 28, 2008
Paul Vaughan-Griffiths has been appointed to the newly created position of vice president of sales and marketing at Legacy Pharmaceuticals International, with the responsibility of overseeing sales and marketing in Europe, Middle East, Asia and Afric…  Read More »
Laureate To Make Interleukin-7 for Cytheris

March 27, 2008
Laureate Pharma has entered into a cGMP contract manufacturing agreement with Cytheris SA, a clinical stage biopharma focused on immune modulation. Laureate will manufacture Cytheris' lead product candidate, Interleukin-7 (IL-7), a fully glycosylated…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: